Berks Hematology Oncology Associates — Reading, Pennsylvania

Berks Hematology Oncology Associates is a clinical research site located in Reading, Pennsylvania, United States 19612.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Berks Hematology Oncology Associates has participated in 2 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia, Multiple Myeloma.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Berks Hematology Oncology Associates?

Berks Hematology Oncology Associates has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Berks Hematology Oncology Associates conducted?

Berks Hematology Oncology Associates has 2 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Multiple Myeloma.

Is Berks Hematology Oncology Associates accredited by Crixeo Health?

Berks Hematology Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Berks Hematology Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.